• Vinod Patil, Gamunu Ratnayake, Galina Fastovets, and D S Wijayatilake.
• Department of Anesthesiology, Queens Hospital, BHR University Hospital NHS Trust Romford, Romford.
• Curr Opin Anaesthesiol. 2018 Jun 1; 31 (3): 280-289.

Purpose Of ReviewAbnormal placentation is a clinical condition seen increasingly in the pregnant population. It is associated with significant morbidity and mortality, which may be mitigated through robust multidisciplinary care for these patients. The role of maternal critical care for these patients has largely been ignored in the literature.Recent FindingsAdvances in pharmacological management of bleeding with recent publications of large multicentre trials in addition to new technologies in the management of massive obstetric haemorrhage (MOH) have revolutionized the management of abnormal placentation. These include the use of tranexamic acid, interventional radiology, cell saver technology, and point-of-care coagulation tests. The role of maternal critical care for the optimization of postoperative complications and physiological derangements has not been considered widely in the literature. This article summarizes the current evidence for interventions and suggests a protocol for the management of these high-risk patients.SummaryA robust protocol outlining the key elements of the management of placenta accreta, including optimizing postoperative care, should be in place to promote desired outcomes.

13 keywords...

hide…